| Primary |
| Drug Use For Unknown Indication |
44.4% |
| Product Used For Unknown Indication |
19.4% |
| Essential Hypertension |
8.3% |
| Prophylaxis |
3.7% |
| Acidosis |
1.9% |
| Cardiac Disorder |
1.9% |
| Depression |
1.9% |
| Hypercholesterolaemia |
1.9% |
| Hyperlipidaemia |
1.9% |
| Hyperparathyroidism |
1.9% |
| Hypertension |
1.9% |
| Hyperuricaemia |
1.9% |
| Parkinson's Disease |
1.9% |
| Type 2 Diabetes Mellitus |
1.9% |
| Anaemia Vitamin B12 Deficiency |
0.9% |
| Atrial Flutter |
0.9% |
| Autoimmune Thyroiditis |
0.9% |
| Bronchiectasis |
0.9% |
| Chest Pain |
0.9% |
| Chronic Ischemic Heart Disease, Unspecified |
0.9% |
|
| Renal Failure Acute |
18.2% |
| Renal Failure |
9.1% |
| General Physical Health Deterioration |
6.1% |
| Pancreatitis Acute |
6.1% |
| Renal Failure Chronic |
6.1% |
| Stupor |
6.1% |
| Thrombocytopenia |
6.1% |
| Ventricular Tachycardia |
6.1% |
| Hyperbilirubinaemia |
3.0% |
| Hypotension |
3.0% |
| Lobar Pneumonia |
3.0% |
| Malaise |
3.0% |
| Pneumonia |
3.0% |
| Prothrombin Time Abnormal |
3.0% |
| Pruritus |
3.0% |
| Respiratory Failure |
3.0% |
| Slow Response To Stimuli |
3.0% |
| Subdural Haematoma |
3.0% |
| Systemic Inflammatory Response Syndrome |
3.0% |
| Tremor |
3.0% |
|
| Secondary |
| Hypertension |
21.9% |
| Pain |
8.2% |
| Cardiac Failure |
7.0% |
| Chronic Obstructive Pulmonary Disease |
7.0% |
| Thrombosis Prophylaxis |
6.4% |
| Essential Hypertension |
6.2% |
| Fluid Replacement |
4.8% |
| Drug Use For Unknown Indication |
4.3% |
| Prophylaxis |
3.9% |
| Myocardial Ischaemia |
3.6% |
| Rash |
3.4% |
| Atrial Fibrillation |
3.1% |
| Systemic Lupus Erythematosus |
3.1% |
| Product Used For Unknown Indication |
3.0% |
| Constipation |
2.5% |
| Sleep Disorder |
2.5% |
| Diabetes Mellitus |
2.3% |
| Hyperuricaemia |
2.3% |
| Hypercholesterolaemia |
2.2% |
| Sedation |
2.2% |
|
| Toxic Epidermal Necrolysis |
20.0% |
| Renal Failure Acute |
9.1% |
| Stevens-johnson Syndrome |
8.2% |
| Syncope |
7.3% |
| Hypotension |
5.5% |
| Prothrombin Time Abnormal |
5.5% |
| Renal Failure Chronic |
5.5% |
| Ventricular Septal Defect |
5.5% |
| Pancreatitis Acute |
4.5% |
| Weight Decreased |
4.5% |
| Swollen Tongue |
3.6% |
| Hyponatraemia |
2.7% |
| Leukopenia |
2.7% |
| Renal Failure |
2.7% |
| Sinoatrial Block |
2.7% |
| White Blood Cell Count Increased |
2.7% |
| Fall |
1.8% |
| Hypovolaemia |
1.8% |
| Pneumonia |
1.8% |
| Renal Function Test Abnormal |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.1% |
| Hypertension |
18.9% |
| Drug Use For Unknown Indication |
13.1% |
| Pain |
4.8% |
| Prophylaxis |
4.7% |
| Atrial Fibrillation |
4.7% |
| Chronic Obstructive Pulmonary Disease |
4.0% |
| Cardiac Failure |
3.7% |
| Rheumatoid Arthritis |
3.2% |
| Coronary Artery Disease |
2.6% |
| Renal Transplant |
2.2% |
| Non-small Cell Lung Cancer |
2.1% |
| Depression |
2.0% |
| Multiple Myeloma |
2.0% |
| Pneumonia |
1.8% |
| Thrombosis Prophylaxis |
1.6% |
| Diabetes Mellitus |
1.6% |
| Hyperlipidaemia |
1.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.4% |
| Oedema |
1.3% |
|
| Renal Failure Acute |
7.4% |
| Vomiting |
7.1% |
| Thrombocytopenia |
6.7% |
| Somnolence |
6.4% |
| Drug Interaction |
6.0% |
| General Physical Health Deterioration |
6.0% |
| Renal Failure |
5.7% |
| Urinary Tract Infection |
5.3% |
| Death |
4.6% |
| Pulmonary Embolism |
4.6% |
| Renal Failure Chronic |
4.6% |
| Weight Increased |
4.6% |
| Sepsis |
4.2% |
| Syncope |
4.2% |
| Clostridium Difficile Colitis |
3.9% |
| Renal Impairment |
3.9% |
| Rhabdomyolysis |
3.9% |
| Weight Decreased |
3.9% |
| Pneumonia |
3.5% |
| Respiratory Moniliasis |
3.5% |
|
| Interacting |
| Hypertension |
35.5% |
| Pain |
7.3% |
| Ascites |
5.5% |
| Product Used For Unknown Indication |
5.5% |
| Gastritis Bacterial |
4.5% |
| Atrial Fibrillation |
3.6% |
| Coronary Artery Disease |
3.6% |
| Hyperlipidaemia |
3.6% |
| Prophylaxis |
3.6% |
| Type 2 Diabetes Mellitus |
3.6% |
| Blood Uric Acid Increased |
2.7% |
| Cardiac Failure |
2.7% |
| Helicobacter Gastritis |
2.7% |
| Leukoencephalopathy |
2.7% |
| Osteoporosis Prophylaxis |
2.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.7% |
| Depression |
1.8% |
| Hashimoto's Encephalopathy |
1.8% |
| Intervertebral Discitis |
1.8% |
| Musculoskeletal Pain |
1.8% |
|
| Renal Failure Acute |
35.3% |
| Sinoatrial Block |
17.6% |
| Pancytopenia |
11.8% |
| Pyrexia |
11.8% |
| Renal Failure Chronic |
11.8% |
| Hyponatraemia |
5.9% |
| Hypotension |
5.9% |
|
